Bicara Therapeutics Inc
NASDAQ:BCAX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bicara Therapeutics Inc
NASDAQ:BCAX
|
US |
|
Walmart Inc
NASDAQ:WMT
|
US |
|
A
|
Ads-Tec Energy PLC
NASDAQ:ADSE
|
IE |
|
Safran SA
OTC:SAFRY
|
FR |
|
G
|
Grupa Kety SA
WSE:KTY
|
PL |
|
Sinfonia Technology Co Ltd
TSE:6507
|
JP |
|
Q
|
Quanta Services Inc
SWB:QAA
|
US |
|
Tigers Polymer Corp
TSE:4231
|
JP |
|
Nanollose Ltd
ASX:NC6
|
AU |
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
US |
|
Piaggio & C SpA
MIL:PIA
|
IT |
|
S
|
Streamplay Studio Ltd
ASX:SP8
|
AU |
|
A
|
Adani Ports and Special Economic Zone Ltd
BSE:532921
|
IN |
|
A
|
Advanced Micro Devices Inc
F:AMD
|
US |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
|
M
|
Motorola Solutions Inc
F:MTLA
|
US |
|
Pegatron Corp
TWSE:4938
|
TW |
|
E
|
Ekachai Medical Care PCL
SET:EKH
|
TH |
|
Tabcorp Holdings Ltd
ASX:TAH
|
AU |
|
V
|
Vaxcell Bio Therapeutics
KOSDAQ:323990
|
KR |
|
K
|
Knowles Corp
F:1K3
|
US |
|
V
|
Vinyl Group Ltd
ASX:VNL
|
AU |
Bankruptcy Probability
Bicara Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Bicara Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bicara Therapeutics Inc
NASDAQ:BCAX
|
1.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
221.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
189.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
72.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
41.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Bicara Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Bicara Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.